What is JBL's health score?

JABIL INC (JBL) has a TradeApes health score of 62 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is JBL's estimated fair value?

Based on our 5-year discounted cash flow model, JABIL INC's estimated fair value is $212.5 per share, representing a -41.7% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is JBL undervalued or overvalued?

Our model currently rates JBL as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for JBL... Refresh in a moment for the full analysis.

JABIL INC (JBL)

Technology Overvalued low healthy

$364.56

Updated: 2026-05-30

TradeApes Score

Financial Strength

75 Strong

Operating Trend

78 Strong

Relative Value

30 Weak

Capital Allocation

60 Healthy

Risk

70 Healthy

Est. Fair Value $212.5

DCF Upside -41.7%

Sector Rank #1175 of 7685

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.